Home › Trial NCT07693374
Chinese Medicinal Component Relieves CIPN and Mitochondria Function
- Trial IDNCT07693374
- StatusWithdrawn
- PhaseN/A
- Study typeInterventional
- SponsorTaiwan Municipal An-Nan Hospital-China Medical University
- Enrollment—
- Start date2022-08-01
- ConditionsBreast Cancer · Chemotherapy-induced Peripheral Neuropathy (CIPN)
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.